dihexa human clinical trials studies Dihexa dihexa human studies clinical trials
Description
The FDA does not verify the safety, effectiveness, or quality of compounded drugs offered at our clinic
2005;288:G422-430
However, available clinical data on TB-500 (TB4), GHK-Cu, and epithalon suggest that said peptides are well-tolerated without any notable side effects [14, 45]
Results expressed as mean SD
